Aroa Biosurgery Limited (ARX.AX)
AUD 0.38
(-9.64%)
AUD 0.38
(-9.64%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -3.74 Million AUD | -64.53% |
| 2023 | -2.27 Million AUD | -747.86% |
| 2022 | -268.61 Thousand AUD | 98.47% |
| 2021 | -17.57 Million AUD | 35.03% |
| 2020 | -27.05 Million AUD | -743.41% |
| 2019 | -3.2 Million AUD | -44.83% |
| 2018 | -2.21 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -4.72 Million AUD | -281.37% |
| 2024 Q4 | -3.74 Million AUD | 20.63% |
| 2024 FY | -3.74 Million AUD | -64.53% |
| 2024 Q1 | 1.8 Million AUD | 179.39% |
| 2024 Q2 | 2.6 Million AUD | 43.96% |
| 2023 Q3 | -2.79 Million AUD | 54.25% |
| 2023 FY | -2.27 Million AUD | -747.86% |
| 2023 Q4 | -2.27 Million AUD | 18.39% |
| 2023 Q2 | -6.1 Million AUD | 0.0% |
| 2022 FY | -268.61 Thousand AUD | 98.47% |
| 2022 Q2 | -37.41 Million AUD | 0.0% |
| 2022 Q4 | -268.61 Thousand AUD | 0.0% |
| 2021 Q4 | -17.57 Million AUD | 0.0% |
| 2021 FY | -17.57 Million AUD | 35.03% |
| 2021 Q2 | -11.22 Million AUD | 0.0% |
| 2020 FY | -27.05 Million AUD | -743.41% |
| 2020 Q4 | 6.8 Million AUD | 0.0% |
| 2019 FY | -3.2 Million AUD | -44.83% |
| 2018 FY | -2.21 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 85.297% |
| Adherium Limited | -6.1 Million AUD | 38.615% |
| Atomo Diagnostics Limited | -3.6 Million AUD | -3.992% |
| Anteris Technologies Ltd | -28.49 Million AUD | 86.852% |
| Control Bionics Limited | -19.02 Thousand AUD | -19599.017% |
| CardieX Limited | 2.74 Million AUD | 236.442% |
| Compumedics Limited | 5.08 Million AUD | 173.661% |
| Cochlear Limited | -269.9 Million AUD | 98.612% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 636.386% |
| Cyclopharm Limited | -7.49 Million AUD | 50.032% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 76.135% |
| Nova Eye Medical Limited | -2.8 Million AUD | -33.731% |
| HeraMED Limited | -799.34 Thousand AUD | -368.775% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 125.873% |
| ImpediMed Limited | -23.48 Million AUD | 84.047% |
| InhaleRx Limited | -155.54 Thousand AUD | -2309.059% |
| LBT Innovations Limited | -604 Thousand AUD | -520.389% |
| Micro-X Limited | 826.99 Thousand AUD | 553.102% |
| Neurotech International Limited | -2.11 Million AUD | -77.55% |
| OncoSil Medical Limited | -4.43 Million AUD | 15.428% |
| PolyNovo Limited | -30.52 Million AUD | 87.725% |
| Respiri Limited | 413.68 Thousand AUD | 1005.788% |
| SomnoMed Limited | -15.16 Million AUD | 75.287% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 29.352% |
| Uscom Limited | -1.53 Million AUD | -144.81% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 8.225% |